HCV New Drug Research: Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and qua
Links shared publicly online about this topic.
- 518total visits
HCV New Drug Research: Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and qua
hepatitiscnewdrugs.blogspot.com —
HCV New Drug Research: Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and qua
View full resource at hepatitiscnewdrugs.blogspot.com
Tags: Liver Condition, Hepatitis, Hepatitis C, Hepatitis C Medication, Drug, Rebetol
Most Recently Shared on February 9, 2011 at 10:29 pm By:
Tina Banwart - HepatitisCNewDrugs
Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in… http://goo.gl/fb/MkblQ
Advertisement
